Abdul E. Mutlib
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Cholinesterase and Neurodegenerative Diseases
- Pharmaceutical Science top 2%
- Chemical Reactions and Isotopes
Papers in
- Pharmacology 22
- Pharmacogenetics and Drug Metabolism 20
- Drug-Induced Hepatotoxicity and Protection 7
- Co-authors
- Robert J. Espina (14 shared papers)Amit S.S. Kalgutkar (3 shared papers)Christopher L. Shaffer (2 shared papers)Joseph T. Strupczewski (2 shared papers)Kirk R. Henne (1 shared paper)Ernesto Callegari (1 shared paper)Yasuhiro Nakai (1 shared paper)Jason Boer (1 shared paper)
- Journals
- Chemical Research in Toxicology (20 papers)Drug Metabolism and Disposition (12 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)Journal of Mass Spectrometry (2 papers)Rapid Communications in Mass Spectrometry (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Abdul E. Mutlib
62 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 135
- Pharmacology 909
- Pharmaceutical Science 188
- Pharmacology 378
- Spectroscopy 379
- Biochemistry 125
Countries citing papers authored by Abdul E. Mutlib
This map shows the geographic impact of Abdul E. Mutlib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdul E. Mutlib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdul E. Mutlib more than expected).
Fields of papers citing papers by Abdul E. Mutlib
This network shows the impact of papers produced by Abdul E. Mutlib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdul E. Mutlib. The network helps show where Abdul E. Mutlib may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdul E. Mutlib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 510 | |
| 2 | 1996 | 230 | |
| 3 | 2008 | 196 | |
| 4 | 1999 | 121 | |
| 5 | 2003 | 120 | |
| 6 | 2015 | 119 | |
| 7 | 2006 | 105 | |
| 8 | 2006 | 102 | |
| 9 | 2008 | 86 | |
| 10 | 2000 | 78 | |
| 11 | 2008 | 77 | |
| 12 | 1995 | 74 | |
| 13 | 2005 | 61 | |
| 14 | 2005 | 60 | |
| 15 | 2010 | 56 | |
| 16 | 2007 | 52 | |
| 17 | 2007 | 45 | |
| 18 | 1994 | 35 | |
| 19 | 1995 | 34 | |
| 20 | 1999 | 33 |
About Abdul E. Mutlib
Abdul E. Mutlib is a scholar working on Pharmacology, Biochemistry, Clinical Biochemistry, Pharmacology and Oncology, having authored 62 papers that have together received 2.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (10 papers), Metabolomics and Mass Spectrometry Studies (9 papers), Analytical Chemistry and Chromatography (8 papers), Metabolism and Genetic Disorders (7 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), HIV/AIDS drug development and treatment (7 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Pharmacology (909 citations), Pharmaceutical Science (188 citations), Pharmacology (378 citations), Spectroscopy (379 citations) and Biochemistry (125 citations). Abdul E. Mutlib has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Robert J. Espina, Amit S.S. Kalgutkar, Christopher L. Shaffer, Joseph T. Strupczewski, Kirk R. Henne, Ernesto Callegari, Yasuhiro Nakai, Jason Boer, Shawn P. Harriman and Iain B. Gardner. Their work appears in journals such as Chemical Research in Toxicology, Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Journal of Mass Spectrometry and Rapid Communications in Mass Spectrometry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.